SWE ORPHAN BIOVITRU
SWE ORPHAN BIOVITRU operates in Diversified Metals & Mining.
SWE ORPHAN BIOVITRU (B6E) - Total Assets
Latest total assets as of September 2024: €72.19 Billion EUR
Based on the latest financial reports, SWE ORPHAN BIOVITRU (B6E) holds total assets worth €72.19 Billion EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SWE ORPHAN BIOVITRU - Total Assets Trend (2016–2023)
This chart illustrates how SWE ORPHAN BIOVITRU’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SWE ORPHAN BIOVITRU - Asset Composition Analysis
Current Asset Composition (December 2023)
SWE ORPHAN BIOVITRU's total assets of €72.19 Billion consist of 17.1% current assets and 82.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 1.2% |
| Accounts Receivable | €5.17 Billion | 7.0% |
| Inventory | €3.87 Billion | 5.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €50.48 Billion | 68.2% |
| Goodwill | €9.64 Billion | 13.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how SWE ORPHAN BIOVITRU's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SWE ORPHAN BIOVITRU's current assets represent 17.1% of total assets in 2023, a decrease from 29.2% in 2016.
- Cash Position: Cash and equivalents constituted 1.2% of total assets in 2023, down from 7.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 81.0% of total assets, an increase from 67.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 68.2% of total assets.
SWE ORPHAN BIOVITRU Competitors by Total Assets
Key competitors of SWE ORPHAN BIOVITRU based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
SWE ORPHAN BIOVITRU - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - SWE ORPHAN BIOVITRU generates 0.30x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, SWE ORPHAN BIOVITRU generates $ 3.25 in net profit.
SWE ORPHAN BIOVITRU - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.91 | 0.81 | 1.28 |
| Quick Ratio | 0.62 | 0.52 | 0.97 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-1.25 Billion | € -2.65 Billion | € 1.58 Billion |
SWE ORPHAN BIOVITRU - Advanced Valuation Insights
This section examines the relationship between SWE ORPHAN BIOVITRU's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 41.0% |
| Total Assets | €74.03 Billion |
| Market Capitalization | $358.38K USD |
Valuation Analysis
Below Book Valuation: The market values SWE ORPHAN BIOVITRU's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SWE ORPHAN BIOVITRU's assets grew by 41.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SWE ORPHAN BIOVITRU (2016–2023)
The table below shows the annual total assets of SWE ORPHAN BIOVITRU from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €74.03 Billion | +41.01% |
| 2022-12-31 | €52.50 Billion | +7.88% |
| 2021-12-31 | €48.66 Billion | +0.78% |
| 2020-12-31 | €48.28 Billion | +5.75% |
| 2019-12-31 | €45.66 Billion | +165.71% |
| 2018-12-31 | €17.18 Billion | +57.60% |
| 2017-12-31 | €10.90 Billion | +9.31% |
| 2016-12-31 | €9.97 Billion | -- |